SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.
In this video, Dr. Tony Kurissery shares some insights into Targeted Protein Degradation and how Syngene has enabled clients working on PROTACs.
In this video, Arunima Mukherjee from Syngene’s Discovery Chemistry team explains synthetic peptides, their applications, and how our team of scientists have enabled the generation of up to 50-mer linear peptides.
In this video, Dr. Ramesh Subbarayan from Syngene’s Discovery Biology team explains the science behind Syngene’s bleomycin-induced pulmonary fibrosis mouse model that is helping advance research in pulmonary fibrosis.
© 2024. Syngene International Limited